Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

Size: px
Start display at page:

Download "Pennino Corporation TECHNOLOGY TO IMPROVE LIFE"

Transcription

1 Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

2 Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety Foreign Governmental Approval Exit / Liquidity Strategies 2

3 The Opportunity A partnership between Pennino Corp. and New York University (NYU) is developing a drug that decreases body fat, increases lean body mass and lowers cholesterol simultaneously Obesity and related diseases like Type 2 Diabetes, Heart Disease, Stroke and Cancer may be prevented or treated with this technology saving millions of lives and billions in healthcare costs Test data indicates fat weight-loss is 5 times greater and 5 times faster than any drug available or in trials today The discovery may be the secret to how the body converts energy from fat to muscle May open a new area of science and could be a Nobel Prize winning breakthrough 3

4 Highlights of Technology and Company Reduces Obesity/Body Fat - Obesity (Adult and Childhood) is the world s number one health epidemic and is directly tied to Cancer, Diabetes, Heart Disease and Stroke Reduces Type 2 Diabetes - Diabetes is directly correlated to obesity and is a leading health expenditure and the #6 cause of death Reduces Cholesterol Our technology has shown to reduce cholesterol better than any existing drug. Cholesterol is a leading heart disease indicator and cholesterol drugs sell over $30Billion annually Increases Lean Body Mass In addition to reducing body fat we are simultaneously increasing lean body mass - a medical miracle World Class University Partner By partnering with NYU, we are working with the top scientists in the world and with cutting-edge equipment IPO/Acquisition Opportunity A drug that can treat ANY of the above diseases is worth billions. We may treat ALL of them and become the biggest drug in history 4

5 Corporate Profile Incorporated in Delaware Filing in February 2007 Company based in New York, NY Joe Pennino is CEO and Chairman The only asset in the Company is the license from NYU (New York University) 5

6 Joe Pennino CEO and Founder Joe Pennino is an experienced CEO and Wall Street veteran who started his career as a CPA with PriceWaterhouseCoopers. He then worked in the institutional capital markets and investment banking at HSBC, Royal Bank of Scotland and Standard Bank and was based out of New York and London. Mr. Pennino is also an investor in technology companies and has been an executive with many early stage technology companies. Mr. Pennino believes the power of science is critical for the health of the global economy and to improve life. Mr. Pennino holds a Masters in Business Administration from Columbia University and has completed coursework at Columbia University Law School. He holds a degree in Accounting and Finance from University of Illinois and has also completed Executive Education at MIT. 6

7 NYU Relationship Pennino Corp. has exclusive, worldwide license for compound(s) discovered at NYU for various disease indications including Obesity, Type 2 Diabetes, and Cholesterol NYU will receive payments for research and royalties on future sales for the life of patents related to this discovery NYU Scientific Team has two senior PhD's planning and directing all testing to obtain the active molecule(s) NYU also has a dedicated technical staff to execute lab work All work is carried out at NYU facilities under strict security and regulatory guidelines 7

8 Obesity in America

9 Obesity Facts The US is currently spending $150 billion (10% of all medical spending) annually on Obesity and related complications, double the cost in 1998, and more than every Cancer put together By 2018, 40% of Americans will be Obese and spending will rise to $344 billion annually By 2030, 86% of Americans will be Overweight and 51% will be Obese Healthcare costs related to Obesity are expect to double each decade and reach $957 billion annually by 2030, or 1 out of every 6 healthcare dollars spent in the US Obesity is attributed to causing the following percentage of cancers: 49% of endometrial, 35% of esophageal, 28% of pancreatic, 24% of kidney, 21% of gallbladder,17% of breast, and 9% of Colon cancer Worldwide, 1.5 billion people will be overweight or obese by

10 Obesity is a Global Problem 10

11 Global Obesity Map 11

12 Childhood Obesity Facts Michelle Obama has launched a new initiative from the White House against Childhood Obesity working with the Human Health Services Department, the Surgeon General and the FDA 33% of all children are Overweight or Obese today 20% of children ages 6 to 11 are Obese today 18% of children ages 12 to 19 are Obese today 33% of children eventually will suffer diabetes and in Latino and African American communities the number will be 50% 20% of children ages 12 to 19 have High Cholesterol 12

13 Global Childhood Obesity is Exploding 13

14 Diabetes Facts The number of Americans with Diabetes is expected to double in the next 25 years from the current 23.7 million to 44.1 million by 2034 Aging Baby Boomers will have a huge effect on Diabetes and Medicare- currently 8.2million with Diabetes are covered by Medicare costing $45 billion annually and by million with Diabetes will be covered by Medicare costing $171 billion annually 57 million Americans are pre-diabetic today 1.6 million new cases of Diabetes are diagnosed each year Diabetes is associated with Heart Disease, Stroke, High Blood Pressure, Blindness, Nervous System Disease, Kidney Disease, and often requires lower limb amputation 14

15 Diabetes in the US 15

16 Global Diabetes Map

17 Correlation of Adult Obesity & Diabetes 17

18 Next Stage of Development Money raised today will complete the isolation of the active molecule(s) NYU has experts in isolating and identifying key molecules from plants Discovery of the molecule is a mathematical process-of-elimination: Assuming there are 500 chemicals in the extract, the scientists will quickly identify and eliminate the vast majority of known chemicals and focus on the remainder until we find the key compound(s) A combination of high tech/expensive equipment, cell culture, and animal studies are being used Once molecule(s) is/are identified, patents will be filed to protect our very valuable intellectual property NYU will likely publish the discovery in medical journals where it should become a global headline story 18

19 Efficacy and Safety The results achieved so far are: significantly greater than those from competitors beyond FDA minimum requirements (5% reduction in body fat) Our test demonstrated close to a 25% reduction in body fat, or 5x greater than necessary Doctors have stated they need to see a 10-15% fat reduction to be considered a useful drug The plant is organic and has been eaten by humans before without negative side effects giving us comfort that this drug is safe. Our own NYU PhD. ate the plant extract himself with: no noticeable negative side effects positive effects of fat reduction, lean body maintenance and lowered cholesterol 19

20 Foreign Government Drug Approval Obesity, Type 2 Diabetes, Cancer, Heart Disease, high Cholesterol, etc are global health problems and Pennino Corp. will seek approval for drug sales in many countries The FDA is often considered the most difficult agency and other agencies move faster with fewer restrictions It is therefore likely that we will be able to sell the drug internationally before we can sell the drug in the US Pennino Corp. will hire the appropriate consultants and work with foreign agencies to meet the requirements to sell our drug in their respective countries Pennino Corp. sees revenue opportunities globally since most people in the world suffer from the diseases we hope to solve 20

21 Exit / Liquidity Strategies IPO There are 2 possible exit strategies: IPO or Acquisition An IPO is most likely to occur around Phase 2 when the valuation has increased within the investing community Proceeds from IPO s are used to continue clinical trials and offers liquidity to investors An IPO for a technology like ours is certain to gather a tremendous amount of interest given the sheer size of the healthcare problems we are addressing Currently we are reviewing the idea of IPO s in New York, London, Dubai and Shanghai 21

22 Exit / Liquidity Strategies - Acquisition An acquisition is the more common route for a bio company and it can happen at any time We would not be surprised to have significant offers even after the patents are filed because Big Pharma is desperate for Patent Pipeline as their important patents are expiring. There is no shortage of both big companies and smaller companies being acquired in recent days: Pfizer acquired Wyeth for $61billion Merck acquired Schering-Plough for $41billion Even smaller, developmental companies get acquired at huge valuations: Cougar Biotechnology was bought by Johnson & Johnson for $1 billion Sirtris was acquired by GlaxoSmithKline for $720 million (FYI, neither of the developmental companies had products approved by the FDA and had drugs for much smaller markets than our target markets. 22

23 Thank You Thank you for reviewing this introductory presentation For more details on the history, data, and future plans, please request our Confidentiality Agreement and we will schedule a meeting with you. We look forward to working with you Joe Pennino CEO and Founder Pennino Corporation

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Oramed Pharmaceuticals, Inc. Initiating Report Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Key data Sector Rating Biotechnology BUY Target Price $45.00

More information

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers

More information

Mineral rights ownership what is it and why is it so unique in the USA?

Mineral rights ownership what is it and why is it so unique in the USA? Mineral rights ownership what is it and why is it so unique in the USA? Introduction This document is designed to explain the concept of mineral rights ownership, and how such ownership differs between

More information

The Burden Of Diabetes And The Promise Of Biomedical Research

The Burden Of Diabetes And The Promise Of Biomedical Research The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed

More information

CHAPTER TWO. The Cost of Obesity

CHAPTER TWO. The Cost of Obesity CHAPTER TWO The Cost of Obesity T he obesity epidemic accounts for a growing share of the nation s health expenditures. U.S. health care costs due to obesity were estimated at $74.2 billion in 1998, or

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information

Alzheimer s disease and diabetes

Alzheimer s disease and diabetes 1007029 CM1053CS Alzheimer s disease and diabetes Nearly 21 million Americans in the United States have diabetes, a disease that makes the body less able to convert sugar to energy. More than 6 million

More information

CAN DIABTES BE PREVENTED OR REVERSED?

CAN DIABTES BE PREVENTED OR REVERSED? Knowledge is power if we use it to invest in our health and future. CAN DIABTES BE PREVENTED OR REVERSED? Old saying: An ounce of prevention is worth a pound of cure Did you know that over one-third of

More information

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS

More information

CE University, Inc. Business Plan Lacture 11B.1. Executive Summary

CE University, Inc. Business Plan Lacture 11B.1. Executive Summary CE University, Inc. Business Plan Lacture 11B.1 The Company Executive Summary CE University, Inc. ( CEU ) is a learning management system company. It is early stage venture that creates and sells online

More information

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? After eating, most food is turned into glucose, the body s main source of energy. 1 Normal Blood

More information

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured.

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured. cruk.org WHAT WE DO Our vision is to bring forward the day when all cancers are cured. Thousands of people are alive today thanks to research. Animal studies have played an important part in this progress.

More information

Why is Diabetes Important To Your Company?

Why is Diabetes Important To Your Company? Why is Diabetes Important To Your Company? An estimated 8% of the Wisconsin adult population has diabetes. It should not be a surprise that employees with diabetes are found at all levels of a company,

More information

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council Diabetes 101 Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council www.diabetes.org 1-800-DIABETES www.diabetes.org 1-800-DIABETES Age-Adjusted

More information

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Patient Tool #1 Understanding Diabetes and Psychiatric Illness: A Guide for Individuals, Families, and Caregivers Type 2 Diabetes,

More information

Masters Learning mode (Форма обучения)

Masters Learning mode (Форма обучения) Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)

More information

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Task Force for the National Conference on Diabetes: The Task Force is comprised of Taking Control of

More information

The Promise and Challenge of Adaptive Design in Oncology Trials

The Promise and Challenge of Adaptive Design in Oncology Trials THE POWER OFx Experts. Experience. Execution. The Promise and Challenge of Adaptive Design in Oncology Trials Clinical oncology trials are more complex and time consuming than those in any other therapeutic

More information

The Commercialization of Technology Concepts into Medical Products

The Commercialization of Technology Concepts into Medical Products The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community

More information

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Jeff Gulcher, MD PhD Chief Scientific Officer and co-founder decode

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures 2011 The University of Texas at Austin IC2 Institute 1 Overview Review of Traditional Innovation

More information

TeachingEnglish Lesson plans. Science and Cloning. Topic: Science vocabulary

TeachingEnglish Lesson plans. Science and Cloning. Topic: Science vocabulary Science and Cloning Topic: Science vocabulary Aims: - To improve oral communication - To link the student's knowledge and interest in science with their English class - To act as an introduction to the

More information

Statistics of Type 2 Diabetes

Statistics of Type 2 Diabetes Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often

More information

The Value of the Laboratory. Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting

The Value of the Laboratory. Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting The Value of the Laboratory Invest Outsource Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting Learning Objectives 1 discuss the state of 2 healthcare in the U.S. understand trends

More information

Facts About the American Cancer Society

Facts About the American Cancer Society Facts About the American Cancer Society About your American Cancer Society The American Cancer Society is the nationwide, community-based voluntary health organization dedicated to eliminating cancer as

More information

Convince Execs Why a Wellness Program Is Worth the Investment

Convince Execs Why a Wellness Program Is Worth the Investment CONNECT WORKPLACE WHITE PAPER Convince Execs Why a Wellness Program Is Worth the Investment CONNECT WORKPLACE WHITE PAPER Convince Execs Why a Wellness Program Is Worth the Investment Copyright 2015 MINDBODY

More information

Is Insulin Effecting Your Weight Loss and Your Health?

Is Insulin Effecting Your Weight Loss and Your Health? Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Technology Intelligence: A Powerful Tool for Competitive Advantage

Technology Intelligence: A Powerful Tool for Competitive Advantage Technology Intelligence: A Powerful Tool for Competitive Advantage Stephen E. Rudolph, Ernest R. Gilmont, Andrew S. Magee, and Nancy F. Smith Among the many management and planning tools that are available

More information

World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health

World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health World Health Day Diabetes and RMNCAH in Africa: R for Reproductive Health Managing diabetes and reproductive health in developing contexts. The 2016 World Health Day theme to scale up prevention, strengthen

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC

Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC Committee on Oversight and Government Reform Domestic Policy Subcommittee U.S. House of

More information

ECONOMIC COSTS OF PHYSICAL INACTIVITY

ECONOMIC COSTS OF PHYSICAL INACTIVITY ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of

More information

230 S. Bemiston; Suite 900 Clayton, MO 63105 (314)727-5522 FAX (314)727-5568 www.mrctbenefitsplus.com www.mrctquote.com

230 S. Bemiston; Suite 900 Clayton, MO 63105 (314)727-5522 FAX (314)727-5568 www.mrctbenefitsplus.com www.mrctquote.com Life & Health Insurance Advisor MRCT Benefits Plus is a comprehensive employee benefits, wellness and Human Resources consulting firm offering a variety of financial services to businesses and individuals

More information

CORPORATE WELLNESS PROGRAM

CORPORATE WELLNESS PROGRAM WEIGHT LOSS CENTERS CORPORATE WELLNESS PROGRAM REDUCE COSTS WITH WORKPLACE WELLNESS 5080 PGA BLVD SUITE 217 PALM BEACH GARDENS, FL 33418 855-771- THIN (8446) www.thinworks.com OBESITY: A PERVASIVE PROBLEM

More information

An Introduction to Valuations

An Introduction to Valuations An Introduction to Valuations PREPARED FOR ROCKY MOUNTAIN BIOBOOSTER MAY 9 TH, 2012 An ICON plc Company Agenda Introductions Valuation methods When is a valuation appropriate? How do you maximize your

More information

Adult Weight Management Training Summary

Adult Weight Management Training Summary Adult Weight Management Training Summary The Commission on Dietetic Registration, the credentialing agency for the Academy of Nutrition and Dietetics Marilyn Holmes, MS, RDN, LDN About This Presentation

More information

A GENERAL DYNAMICS COMPANY

A GENERAL DYNAMICS COMPANY A GENERAL DYNAMICS COMPANY Forget your credit score and your PIN for now. The numbers that can really determine your future are found in some simple lab results. Cholesterol. Blood pressure. Blood glucose.

More information

Diabetes & blindness. due to DME BLINDNESS IN EUROPE

Diabetes & blindness. due to DME BLINDNESS IN EUROPE Diabetes & blindness due to DME BLINDNESS IN EUROPE Blindness is a life-changing disability which puts a heavy strain on the daily lives of sufferers, their families, and society at large. Today, 284 million

More information

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative

More information

Understanding Obesity

Understanding Obesity Your Guide to Understanding Obesity As your partner in health for your life s journey, we want you to be as informed and confident as possible regarding the disease or medical issue you may be facing.

More information

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY Understanding the Complications That May Happen Without Proper Care STAYING HEALTHY THE IMPORTANCE OF PROPER MANAGEMENT OF TYPE 2 DIABETES Diabetes is

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

Example of Type 2 Diabetes

Example of Type 2 Diabetes Why Health Insurance Reform? The Example of Type 2 Diabetes Millard, Ann V., Margaret A. Graham, Nelda Mier, and Isidore Flores Diane Ariza, Moderator Health Issues Confronting Latinos/as Latino/a Communities

More information

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes

More information

Wasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs

Wasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs by Christopher J. Mathews Wasteful spending in the U.S. health care system costs an estimated $750 billion to $1.2 trillion

More information

Reducing Waste with an Efficient Medicare Prescription Drug Benefit

Reducing Waste with an Efficient Medicare Prescription Drug Benefit Issue Brief January 2013 Reducing Waste with an Efficient Medicare Prescription Drug Benefit BY DEAN BAKER* When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that

More information

What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body.

What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body. What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body. Most of the food we eat is turned into glucose, a form of sugar. We

More information

Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update

Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update Background Overweight and obesity have greatly increased among all age groups and regardless of income and education. Contributing

More information

Technological Advances in the Medical Field, Human Health and Aging

Technological Advances in the Medical Field, Human Health and Aging 1 EGN 1033 Technology Humans and Society Technological Advances in the Medical Field, Human Health and Aging Tatiana Fuentes Daniel Garcia Beatriz Varela Florida International University 10555 West Flagler

More information

How To Lose Weight With Diabetes

How To Lose Weight With Diabetes 1 of 5 1/9/2014 9:22 AM Published: Summer 2013 Margaret Stevens was diagnosed with Type 2 diabetes nearly three decades ago. A Type 2 diabetic, Margaret Stevens has lost over 100 pounds and has her glucose

More information

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this

More information

The Curriculum of Health and Nutrition Education in Czech Republic Jana Koptíková, Visiting Scholar

The Curriculum of Health and Nutrition Education in Czech Republic Jana Koptíková, Visiting Scholar The Curriculum of Health and Nutrition Education in Czech Republic Jana Koptíková, Visiting Scholar ABSTRACT The average one-year health expenditure per capita in the European member states has doubled

More information

The Health Care Law and

The Health Care Law and The Health Care Law and The Problem Insurance companies were not held accountable and could turn away some of the 129 million Americans with pre-existing conditions. Premiums had more than doubled over

More information

A Letter from MabVax Therapeutics President and Chief Executive Officer

A Letter from MabVax Therapeutics President and Chief Executive Officer A Letter from MabVax Therapeutics President and Chief Executive Officer Dear Fellow Stockholder: You have invested in MabVax Therapeutics because you share our passion for finding new therapies for the

More information

Chronic Disease and Nursing:

Chronic Disease and Nursing: Chronic Disease and Nursing: A Summary of the Issues What s the issue? Chronic diseases are now the major global disease problem facing the world and a key barrier to development, to alleviating poverty,

More information

HEALTH CARE COSTS 11

HEALTH CARE COSTS 11 2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about

More information

Engineering for the new pharma reality

Engineering for the new pharma reality NNE Pharmaplan is an international company specialised in pharma engineering. We help pharmaceutical companies bring products to market by providing flexible, compliant and future-proof solutions. We have

More information

Detecting Cancer in Blood. Company presentation

Detecting Cancer in Blood. Company presentation Detecting Cancer in Blood Company presentation Safe harbor statement Forward Looking Statements This communication contains certain forward-looking statements, including, without limitation, statements

More information

EXPANSION. The Hormel Institute University of Minnesota LIVE LEARNING CENTER

EXPANSION. The Hormel Institute University of Minnesota LIVE LEARNING CENTER 2016 The Hormel Institute University of Minnesota LIVE LEARNING CENTER Cancer is a devastating disease that affects all our lives. In the past two decades, cancer death rates have decreased by 22% because

More information

the solution. I think too much of the health care issues we re faced with as opposed to the problem.

the solution. I think too much of the health care issues we re faced with as opposed to the problem. Introduction: Hi I m Sherrie Bossing and I manage Lilly s corporate brand and volunteer strategy worldwide. I m joined today with Dr. Jack Harris who is the Vice President responsible for US Medical Division,

More information

Like John Fogerty said in one of his hit songs, I see a bad moon arising, How to Decrease Your Health Care Costs for Employees with Diabetes

Like John Fogerty said in one of his hit songs, I see a bad moon arising, How to Decrease Your Health Care Costs for Employees with Diabetes How to Decrease Your Health Care Costs for Employees with Diabetes Written by Tom Milam Like John Fogerty said in one of his hit songs, I see a bad moon arising, I see trouble on the way, the self-insured

More information

When treating a disease is bad business: orphan and neglected diseases

When treating a disease is bad business: orphan and neglected diseases When treating a disease is bad business: orphan and neglected diseases Rocío Acuña Hidalgo Introduction Over the past decades, the development of thousands of new drugs to treat diseases has improved the

More information

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements November 2015 Presented by: Stephen Thau 2 BIOTECH IPOS ARE HOT! The Biggest Biotech

More information

CRITICAL ILLNESS INSURANCE. ExtensiA. The ideal complement to your group insurance

CRITICAL ILLNESS INSURANCE. ExtensiA. The ideal complement to your group insurance CRITICAL ILLNESS INSURANCE ExtensiA The ideal complement to your group insurance Peace of mind within your reach Today, progress in medicine and breakthroughs in research have significantly extended our

More information

Why Disruptive Innovations Matter in Laboratory Diagnostics

Why Disruptive Innovations Matter in Laboratory Diagnostics Article: S. Nam.. Clin Chem 2015;61:935-937. http://www.clinchem.org/content/61/7/935.extract Guest: Spencer Nam is a Research Fellow specializing in healthcare at the Clayton Christensen Institute for

More information

Diabetes for CNAs. This course has been awarded two (2.0) contact hours. This course expires on January 31, 2017.

Diabetes for CNAs. This course has been awarded two (2.0) contact hours. This course expires on January 31, 2017. Diabetes for CNAs This course has been awarded two (2.0) contact hours. This course expires on January 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction and distribution of these materials

More information

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs T H E F A C T S A B O U T Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs Upstate New York Adults with diagnosed diabetes: 2003: 295,399 2008: 377,280 diagnosed

More information

I would like to thank the Ministry of Higher Education and all of our friends and

I would like to thank the Ministry of Higher Education and all of our friends and 1 Internationalization and Globalization in Higher Education Joe Glover, Provost and Senior Vice President, University of Florida International Exhibition for Higher Education January 26 29, 2010 Riyadh,

More information

Evaluating New Cancer Treatments

Evaluating New Cancer Treatments Evaluating New Cancer Treatments You ve just heard about a possible new cancer treatment and you wonder if it might work for you. Your doctor hasn t mentioned it, but you want to find out more about this

More information

The UnitedHealthcare Diabetes Health Plan Better information. Better decisions. Better results. Agenda

The UnitedHealthcare Diabetes Health Plan Better information. Better decisions. Better results. Agenda The UnitedHealthcare Better information. Better decisions. Better results. 1 Agenda Market Health Trends- declining health status and increase disease prevalence Optimal Decisions and Opportunity for Improvement

More information

The Cell Therapy Catapult

The Cell Therapy Catapult The Cell Therapy Catapult Keith Thompson CEO January 29 2013 info@ct.catapult.org.uk Catapult is a Technology Strategy Board programme The Launch of Catapults Hauser 2 Hauser Report Creating new manufacturing

More information

The Health Care Law and

The Health Care Law and The Health Care Law and Office of the Regional Director Community Resource California-Based, extensive travel to NV, AZ, and HI. Day-to-day, week-to-week, month-to-month Educate the public on the benefits

More information

Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011

Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011 Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011 Indian Health Service Overview by Yvette Roubideaux, M.D., M.P.H. Director, Indian Health Service (The Patty Iron Cloud

More information

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH

4/4/2013. Mike Rizo, Pharm D, MBA, ABAAHP THE PHARMACIST OF THE FUTURE? METABOLIC SYNDROME AN INTEGRATIVE APPROACH METABOLIC SYNDROME AN INTEGRATIVE APPROACH AN OPPORTUNITY FOR PHARMACISTS TO MAKE A DIFFERENCE Mike Rizo, Pharm D, MBA, ABAAHP THE EVOLUTION OF THE PHARMACIST 1920s 1960s 2000s THE PHARMACIST OF THE FUTURE?

More information

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases Scott Johnson CEO, President and Founder Introduction Broken system of medical research No fault, system

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells Pharmaceutical Report Royalty Purchasing Industry Thomas R. Wells Table of Contents Industry Overview 2 How Transactions Work 2 Advantages & Disadvantages for Inventors and Investors 4 Major Investors

More information

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY NINESIGMA WHITE PAPER OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY How six leading healthcare companies are leveraging Open Innovation to achieve their innovation goals By: Stephen Clulow, Director

More information

YOUR LAST DIET IDEAL PROTEIN

YOUR LAST DIET IDEAL PROTEIN YOUR LAST DIET IDEAL PROTEIN OBJECTIVES Explain the science and history that supports the Ideal Protein Diet method. Describe the risks and benefits of diet participation. Give you the details of what

More information

http://www.fda.gov/forconsumers/consumerupdates/ucm341344.htm?source=govdelivery.

http://www.fda.gov/forconsumers/consumerupdates/ucm341344.htm?source=govdelivery. 6 Tip-offs to Rip-offs: Don't Fall for Health Fraud Scams The US Food and Drug Administration has published a paper on how we as consumers and avoid getting ripped off by health fraud scams. This paper

More information

Medical Billing Strategies for EMD - hospital ERM

Medical Billing Strategies for EMD - hospital ERM s Technology and Services Analyst Meeting May 4, 2006 Healthcare Healthcare Overview Vishal Wanchoo President & CEO, Healthcare IT 2 / Title or job number Healthcare business model Differentiate with technology

More information

Diabetes The Basics. What is Diabetes? How does sugar get into your cells? Type 1 diabetes. Type 2 diabetes. Why control Diabetes?

Diabetes The Basics. What is Diabetes? How does sugar get into your cells? Type 1 diabetes. Type 2 diabetes. Why control Diabetes? Diabetes The Basics What is Diabetes? Diabetes is when there is too much sugar in your blood. Sugar from food you eat and drink stays in your blood instead of going into the cells in your body. The cells

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

County of Santa Clara Public Health Department

County of Santa Clara Public Health Department County of Santa Clara Public Health Department PH05 042710. DATE: April 27, 2010 Prepared by:. Colleen Martin Health Care Program Manager TO: Board of Supervisors FROM: Dan Peddycord, RN, MPA/HA Public

More information

OPKO Health to Acquire Bio-Reference Laboratories

OPKO Health to Acquire Bio-Reference Laboratories OPKO Health to Acquire Bio-Reference Laboratories - Complementary in-depth expertise in diagnostics business with state of the art experience in use of genomic data for personalized therapy - Acquisition

More information

Monetary and Political Effects of Product Liability Lawsuits in. the Pharmaceutical Industry. Constructed By: Spenser Hanson.

Monetary and Political Effects of Product Liability Lawsuits in. the Pharmaceutical Industry. Constructed By: Spenser Hanson. Monetary and Political Effects of Product Liability Lawsuits in the Pharmaceutical Industry Constructed By: Spenser Hanson Joe Wadle October 24 th, 2009 G400: Professor Andreas Hauskrecht Introduction

More information

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer TOP 10 TRENDS IN HEALTHCARE, MEDICAL AND PHARMACEUTICAL INDUSTRY HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer KPJSeremban Specialist Hospital KPJ SEREMBAN SPECIALIST HOSPITAL Presented by : Hj Abd

More information

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease

Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)

More information

Sosei acquires Jitsubo, a leading Japanese peptide technology company

Sosei acquires Jitsubo, a leading Japanese peptide technology company Sosei acquires Jitsubo, a leading Japanese peptide technology company Tokyo, Japan 11 December 2014: Sosei Group Corporation ( The Group ; TSE Mothers Index: 4565) is pleased to announce that at the meeting

More information

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy

More information

Healthcare Recruiting with Social Media. Brought to you by

Healthcare Recruiting with Social Media. Brought to you by Healthcare Recruiting with Social Media Brought to you by Table of Contents Introduction 3 Healthcare Recruiting Best Practices 5 Reach Job Candidates in the Right Places, on the Right Devices 6 Use Targeted

More information

TABLE OF CONTENTS. The Cost of Diabesity... 3. Employer Solutions... 4 Provide a Worksite Weight Loss Program Tailored for Diabetes...

TABLE OF CONTENTS. The Cost of Diabesity... 3. Employer Solutions... 4 Provide a Worksite Weight Loss Program Tailored for Diabetes... TH E TABLE OF CONTENTS The Cost of Diabesity... 3 Employer Solutions... 4 Provide a Worksite Weight Loss Program Tailored for Diabetes... 4 Provide Healthy Food Options at the Workplace... 4 Make it Easy

More information

Managing Your Weight After a Cancer Diagnosis. A Guide for Patients and Families

Managing Your Weight After a Cancer Diagnosis. A Guide for Patients and Families Managing Your Weight After a Cancer Diagnosis A Guide for Patients and Families ABOUT ASCO Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world s leading professional organization

More information

What s the Cost of Spending and Saving?

What s the Cost of Spending and Saving? LESSON DESCRIPTION AND BACKGROUND This lesson examines the benefits and opportunity cost of spending and saving. The students learn how compound interest makes savings grow. Compounding provides an incentive

More information

Do You Know the Health Risks of Being Overweight?

Do You Know the Health Risks of Being Overweight? Do You Know the Health Risks of Being Overweight? U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH WIN Weight-control Information Network What are the risks to my health from

More information

An Overview: Consumer Facing Digital Health Technology: What Is It and What Are The Challenges?

An Overview: Consumer Facing Digital Health Technology: What Is It and What Are The Challenges? An Overview: Consumer Facing Digital Health Technology: What Is It and What Are The Challenges? Ted Vickey MSc, PhD (ABD) President FitWell LLC Institute of Medicine Roundtable on Health Literacy Washington,

More information